Correlation Between Allarity Therapeutics and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Allarity Therapeutics and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Lixte Biotechnology.
Diversification Opportunities for Allarity Therapeutics and Lixte Biotechnology
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Allarity and Lixte is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and Lixte Biotechnology
Given the investment horizon of 90 days Allarity Therapeutics is expected to under-perform the Lixte Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Allarity Therapeutics is 2.2 times less risky than Lixte Biotechnology. The stock trades about -0.1 of its potential returns per unit of risk. The Lixte Biotechnology Holdings is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 160.00 in Lixte Biotechnology Holdings on October 24, 2024 and sell it today you would earn a total of 73.00 from holding Lixte Biotechnology Holdings or generate 45.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allarity Therapeutics vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Allarity Therapeutics |
| Lixte Biotechnology |
Allarity Therapeutics and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allarity Therapeutics and Lixte Biotechnology
The main advantage of trading using opposite Allarity Therapeutics and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.| Allarity Therapeutics vs. Nuvalent | Allarity Therapeutics vs. Arcellx | Allarity Therapeutics vs. Vaxcyte | Allarity Therapeutics vs. Crinetics Pharmaceuticals |
| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |